Related Experiment Video
Updated: Jul 17, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
How Does Omitting Additional Surgery After Local Excision Affect the Prognostic Outcome of Patients With High-risk T1
Akira Ouchi1, Koji Komori1, Tajika Masahiro2
1Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Aichi, Japan.
Omitting additional surgery after local excision for high-risk T1 colorectal cancer (CRC) resulted in few oncologic events and good cancer-specific survival. However, overall survival was lower without the additional surgery, highlighting the need for individualized risk assessment.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- The necessity of additional surgery after local excision (LE) for high-risk T1 colorectal cancer (CRC) remains debated.
- Patient tolerability of invasive procedures influences treatment decisions.
Purpose of the Study:
- To evaluate the impact of omitting additional surgery on patient outcomes in high-risk T1 CRC.
- To compare outcomes between patients who underwent LE with additional surgery versus LE alone.
Main Methods:
- Analysis of patients with T1 CRC treated with LE between 2009-2016 at Japanese Society for Cancer of the Colon and Rectum institutions.
- Propensity score-matching to create one-to-one pairs of patients who received LE with surgery versus LE alone.
- Comparison of oncologic outcomes and survival rates between matched groups (401 pairs).
Main Results:
- Regional lymph node metastasis occurred in 7.7% of patients in the LE + surgery group.
- The LE-alone group showed low 5-year cumulative risks for local recurrence (4.1%) and overall recurrence (5.5%).
- A minimal difference in 5-year cancer-specific survival (1.8%) was observed, but 5-year overall survival was significantly lower in the LE-alone group (88.5% vs 94.5%).
Conclusions:
- Omitting additional surgery in dedicated CRC centers led to few oncologic events and satisfactory cancer-specific survival.
- Individualized risk assessment, considering non-oncologic adverse events, is crucial for optimal treatment strategies.
- Further evaluation is needed to balance oncologic control with non-oncologic risks for high-risk T1 tumors.
More Related Videos
08:26Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
Published on: March 24, 2023
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022